Pharmaceutical Launch Excellence ― Bringing a New Drug to Market Successfully

Planning and implementing a new drug launch strategy is a complex process that requires everyone involved to have a clear sense of what success looks like and to plan how to deliver that success. Colin Wight's Pharmaceutical Launch Excellence is a 'must have' guide to the process that explains all of the variables at work and offers pragmatic advice to help pharma executives secure market access, stakeholder advocacy and establish a realistic governance model for the process. The book also provides a set of commercial models to underpin a launch strategy as well as a suite of metrics for measuring success.

Colin Wight, Chief Executive, founded GalbraithWight Ltd, the Strategic Healthcare Business Consultancy, in January 1997. Starting originally with Glaxo in R&D, Colin has thirty years healthcare industry experience, including twelve years with Merck & Co Inc, three years as Marketing Director for Rhone-Poulenc Rorer (now Sanofi-Aventis), and four years as Sales Director and Sales and Marketing Director for Bristol-Myers Squibb. Colin has been a member of global strategic marketing teams for cardiovascular and respiratory products, and global salesforce effectiveness teams. He has worked alongside leading management consultants including McKinsey and Boston Consulting, and has worked with the positioning experts and well-known authors Al Ries and Jack Trout. He has been responsible for some of the most successful launches, including Innovace and Zocor. Most recently, Colin authored Scrip’s Guide to Successful Pharmaceutical Marketing; a detailed insight into pharmaceutical marketing in the 21st Century.